Literature DB >> 16044458

Nucleotide -88 (C-T) promoter mutation is a common beta-thalassemia mutation in the Jat Sikhs of Punjab, India.

Gurjeewan Garewal1, Reena Das, Jasmina Ahluwalia, R K Marwaha, S Varma.   

Abstract

A study of beta-gene mutations in Jat Sikhs, a subcaste of Punjabis, revealed a very high prevalence (46%: 41/88) of the mild beta++ promoter region mutation -88 (C-T). Sixteen individuals presenting in homozygous form were clinically mild. Un-transfused patients had characteristic hematological findings: high Hb F (38.1-68.6%, mean 47.4%), high Hb A2 (5.7-9.8%, mean 6.88%), and the rest had adult hemoglobin. The 19 subjects with compound heterozygosity for -88 (C-T) and another beta-gene mutation presented both as thalassemia intermedia (four cases) and as thalassemia major (15 cases). One of the four patients with the milder phenotype had a second mild mutation, CAP+1 (beta++). In the other three cases with the milder phenotype, the second mutation was associated with the presence of the XmnI Ggamma polymorphism. Notably, the XmnI Ggamma was negative in all the -88 (C-T) alleles. None of the patients had associated alpha-thalassemia even in the thalassemia intermedia group. Haplotype analysis of the -88 (C-T) homozygous cases showed a single haplotype (+ - - - - + -) in all but two individuals. This haplotype is distinct from those described in the Africans with homozygous -88 (C-T), suggesting that the mutation in our population occurred independently. Copyright (c) 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16044458     DOI: 10.1002/ajh.20445

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  7 in total

1.  A descriptive profile of β-thalassaemia mutations in India, Pakistan and Sri Lanka.

Authors:  M L Black; S Sinha; S Agarwal; R Colah; R Das; M Bellgard; A H Bittles
Journal:  J Community Genet       Date:  2010-10-10

2.  Profiling β-thalassaemia mutations in India at state and regional levels: implications for genetic education, screening and counselling programmes.

Authors:  S Sinha; M L Black; S Agarwal; R Colah; R Das; K Ryan; M Bellgard; A H Bittles
Journal:  Hugo J       Date:  2010-02-10

3.  Sickle Cell Disease in Central India: A Potentially Severe Syndrome.

Authors:  Dipty Jain; Vinit Warthe; Paridhi Dayama; Dilip Sarate; Roshan Colah; Pallavi Mehta; Graham Serjeant
Journal:  Indian J Pediatr       Date:  2016-04-07       Impact factor: 1.967

4.  Extreme Genotype/Phenotype Heterogeneity of Double Heterozygous Sickle β-Thalassemia in a Family: Implications in Antenatal Diagnosis.

Authors:  Diksha Dev Yadav; Namrata Singh; Sreejesh Sreedharanunni; Jasbir Kaur Hira; Sanjeev Chhabra; Amita Trehan; Subhash Saha; Prashant Sharma; Reena Das
Journal:  Indian J Hematol Blood Transfus       Date:  2021-03-04       Impact factor: 0.915

5.  Mutational spectrum of thalassemias in India.

Authors:  Inusha Panigrahi; R K Marwaha
Journal:  Indian J Hum Genet       Date:  2007-01

Review 6.  Past, present & future scenario of thalassaemic care & control in India.

Authors:  Ishwar C Verma; Renu Saxena; Sudha Kohli
Journal:  Indian J Med Res       Date:  2011-10       Impact factor: 2.375

7.  Genetic Heterogeneity of Beta Globin Mutations among Asian-Indians and Importance in Genetic Counselling and Diagnosis.

Authors:  Ravindra Kumar; Kritanjali Singh; Inusha Panigrahi; Sarita Agarwal
Journal:  Mediterr J Hematol Infect Dis       Date:  2013-01-02       Impact factor: 2.576

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.